{"hands_on_practices": [{"introduction": "The journey from gene to protein begins with transcription, a process tightly controlled by specific DNA sequences known as promoters. This first exercise focuses on the TATA box, a key component of many promoters that acts as a landing pad for the transcription machinery. By considering the consequence of its deletion, you can solidify your understanding of how fundamental DNA elements govern gene activation and cellular responses [@problem_id:2336766].", "problem": "Astrocytes, a type of glial cell in the central nervous system, play a crucial role in responding to brain injury. A key feature of this response, known as reactive astrogliosis, is the massive upregulation of an intermediate filament protein called Glial Fibrillary Acidic Protein (GFAP). This increase in GFAP protein is primarily driven by a sharp increase in the transcription of the GFAP gene.\n\nIn eukaryotes, the initiation of transcription by RNA Polymerase II depends on the assembly of a preinitiation complex on a region of the gene known as the core promoter. A common and critical DNA sequence element within many core promoters is the TATA box, which typically has the consensus sequence 5'-TATAAA-3'.\n\nConsider a hypothetical scenario where a specific mutation completely deletes the TATA box from the core promoter of the GFAP gene in a line of cultured human astrocytes. These modified astrocytes are then subjected to a chemical stimulus that mimics brain injury and normally induces strong GFAP expression in wild-type (unmutated) cells.\n\nWhich of the following statements most accurately predicts the effect of this TATA box deletion on GFAP protein levels in the mutated astrocytes following the injury stimulus, as compared to wild-type astrocytes receiving the same stimulus?\n\nA. The injury stimulus will fail to cause the characteristic large increase in GFAP protein levels.\n\nB. GFAP protein levels will be unaffected by the mutation and will increase normally after the injury stimulus.\n\nC. GFAP protein will be expressed at extremely high levels even without the injury stimulus.\n\nD. The GFAP gene will be transcribed correctly, but the resulting messenger RNA (mRNA) will be unstable and degraded before it can be translated into protein.\n\nE. The GFAP protein will be synthesized in normal quantities, but it will be improperly folded and non-functional.", "solution": "The central question concerns how the deletion of the TATA box from the GFAP gene promoter affects the cell's ability to produce GFAP protein, particularly in response to a stimulus that normally causes a large increase in its expression. To answer this, we must understand the role of the TATA box in gene transcription.\n\nFirst, let's review the flow of genetic information: DNA is transcribed into messenger RNA (mRNA), and mRNA is translated into protein. The regulation of protein levels is most often controlled at the level of transcription.\n\nThe process of transcription is initiated when an enzyme, RNA Polymerase II, binds to a specific region of a gene called the promoter. The core promoter contains specific DNA sequences that are recognized by general transcription factors, which are proteins that recruit RNA Polymerase II and help it to start transcribing.\n\nThe TATA box is one of the most well-known core promoter elements. Its function is to be the binding site for a crucial general transcription factor called the TATA-binding protein (TBP), which is itself a subunit of a larger complex, TFIID. The binding of TBP to the TATA box is a critical initial step that correctly positions the entire transcription preinitiation complex, including RNA Polymerase II, at the transcription start site. This assembly is essential for efficient and accurate transcription initiation.\n\nIn the scenario described, the astrocytes are responding to an injury stimulus by dramatically upregulating GFAP expression. This requires a rapid and massive increase in the rate of transcription of the GFAP gene. Such a high level of induced expression is heavily reliant on a functional and efficient promoter.\n\nThe mutation described is a complete deletion of the TATA box. Without the TATA box, the TATA-binding protein (TBP) cannot bind effectively to the GFAP gene's promoter. The failure of TBP to bind will severely impair or completely prevent the assembly of the preinitiation complex at the correct location. Consequently, RNA Polymerase II will not be efficiently recruited to the gene, and the initiation of transcription will be drastically reduced or abolished entirely. While some genes (TATA-less promoters) can be transcribed without a TATA box using other initiator elements, the strong, inducible expression characteristic of the GFAP response is highly dependent on a strong promoter, for which the TATA box is a key component.\n\nTherefore, even when the injury stimulus is present, the cell's machinery will be unable to carry out the necessary high-level transcription of the GFAP gene. The result will be very little or no new GFAP mRNA being produced, and consequently, a failure to synthesize the large amounts of GFAP protein that characterize reactive astrogliosis.\n\nLet's evaluate the options based on this analysis:\n- A. The injury stimulus will fail to cause the characteristic large increase in GFAP protein levels. This matches our conclusion perfectly. The machinery for transcription initiation is broken, so the upregulation signal cannot be executed.\n- B. GFAP protein levels will be unaffected by the mutation and will increase normally after the injury stimulus. This is incorrect because it ignores the fundamental role of the TATA box in enabling efficient transcription.\n- C. GFAP protein will be expressed at extremely high levels even without the injury stimulus. This is incorrect. The TATA box is an activating element required for transcription to *occur*; its deletion would inhibit, not constitutively activate, expression. This option confuses a promoter element with a repressor element.\n- D. The GFAP gene will be transcribed correctly, but the resulting messenger RNA (mRNA) will be unstable and degraded. This is incorrect. The TATA box deletion affects the very first step, transcription initiation. It does not affect post-transcriptional processes like mRNA stability.\n- E. The GFAP protein will be synthesized in normal quantities, but it will be improperly folded and non-functional. This is incorrect. The mutation affects the *quantity* of protein produced by disrupting transcription. It does not alter the genetic code of the protein itself, so any protein that might be made would have the correct amino acid sequence. This option confuses an issue of gene regulation with a post-translational issue like protein folding.\n\nThus, the most accurate prediction is that the TATA box deletion will prevent the stimulus-induced upregulation of GFAP protein.", "answer": "$$\\boxed{A}$$", "id": "2336766"}, {"introduction": "Once a gene is transcribed into pre-mRNA, it's like a film director's rough cut, containing both the essential scenes (exons) and the parts that will be left on the cutting room floor (introns). The process of splicing edits this transcript into a final, coherent message. This exercise allows you to practice the fundamental arithmetic of splicing by calculating the final mRNA length when a specific exon is skipped, a common form of alternative splicing [@problem_id:2336781].", "problem": "The pre-messenger RNA (pre-mRNA) of a neuron-specific gene encoding a dopamine receptor is transcribed from a DNA template. This initial transcript is composed of six coding regions, called exons, which are interrupted by five non-coding regions, called introns. The structure of the pre-mRNA is as follows, with the length of each segment given in nucleotides (nt):\n\n- Exon 1: 150 nt\n- Intron 1: 300 nt\n- Exon 2: 121 nt\n- Intron 2: 150 nt\n- Exon 3: 88 nt\n- Intron 3: 420 nt\n- Exon 4: 57 nt\n- Intron 4: 210 nt\n- Exon 5: 110 nt\n- Intron 5: 180 nt\n- Exon 6: 250 nt\n\nIn a healthy neuron, the pre-mRNA undergoes a process called splicing, where all introns are removed and the exons are joined together to form a mature messenger RNA (mRNA) transcript. However, a specific point mutation has occurred in a regulatory sequence, causing the splicing machinery to completely skip Exon 4, effectively treating it as part of an intron and removing it along with the surrounding introns.\n\nWhat is the total length of the mature mRNA transcript produced in a neuron carrying this mutation? Select the correct length from the options below.\n\nA. 776 nt\n\nB. 719 nt\n\nC. 2036 nt\n\nD. 1979 nt\n\nE. 57 nt", "solution": "Splicing removes all introns in both healthy and mutant neurons. Therefore, the length of a mature mRNA equals the sum of the exons that are retained.\n\nLet the exon lengths be\n$$E_{1}=150,\\ E_{2}=121,\\ E_{3}=88,\\ E_{4}=57,\\ E_{5}=110,\\ E_{6}=250.$$\n\nIn a healthy neuron, the mature mRNA length is the sum of all exons:\n$$L_{\\text{healthy}}=E_{1}+E_{2}+E_{3}+E_{4}+E_{5}+E_{6}=150+121+88+57+110+250=776.$$\n\nWith exon 4 skipped, the splicing still removes all introns, but exon 4 is not included. Hence, the mutant mature mRNA length is\n$$L_{\\text{mutant}}=E_{1}+E_{2}+E_{3}+E_{5}+E_{6}=L_{\\text{healthy}}-E_{4}=776-57=719.$$\n\nThus, the correct option is the length 719 nt.", "answer": "$$\\boxed{B}$$", "id": "2336781"}, {"introduction": "Not all messages transcribed from DNA are perfect; mutations can introduce errors that would lead to non-functional or even toxic proteins. To guard against this, cells employ sophisticated quality control systems. This final practice explores Nonsense-Mediated Decay (NMD), a surveillance pathway that identifies and destroys mRNAs containing premature termination codons, connecting the process of splicing to a crucial cellular safety check [@problem_id:2336778].", "problem": "In cellular and molecular neuroscience, the fidelity of protein synthesis is critical for neuronal function. Cells have evolved surveillance mechanisms to eliminate faulty messenger RNA (mRNA) transcripts. One such mechanism is Nonsense-Mediated Decay (NMD), which targets mRNAs containing a premature termination codon (PTC) for degradation.\n\nConsider a hypothetical gene, `NEURONIN` (`NRN1`), which is crucial for synaptic plasticity. The coding sequence of `NRN1` is composed of five exons with the following lengths:\n*   Exon 1: 90 nucleotides (nt)\n*   Exon 2: 120 nt\n*   Exon 3: 150 nt\n*   Exon 4: 110 nt\n*   Exon 5: 180 nt (This final exon contains the physiological stop codon)\n\nThe NMD pathway is triggered if a PTC is located more than a critical distance, `D_crit = 55` nucleotides, upstream of the final exon-junction complex (EJC). During splicing, an EJC is deposited on the mRNA transcript at the location of each spliced-out intron, effectively marking the exon-exon boundaries. For this problem, assume the EJC is positioned precisely at the junction point.\n\nTwo different patient-derived cell lines are analyzed, each with a distinct single-nucleotide mutation in the `NRN1` gene:\n*   **Mutation A:** A nonsense mutation that creates a PTC at a position 80 nucleotides into the sequence of Exon 2.\n*   **Mutation B:** A nonsense mutation that creates a PTC at a position 100 nucleotides into the sequence of Exon 4.\n\nAssuming transcription and splicing occur normally for both mutant alleles, which of the following statements accurately describes the fate of the resulting `NRN1` mRNA transcripts in the respective cell lines?\n\nA. Both transcripts will be degraded by NMD.\n\nB. Neither transcript will be degraded by NMD.\n\nC. The transcript from Mutation A will be degraded by NMD, but the transcript from Mutation B will not.\n\nD. The transcript from Mutation B will be degraded by NMD, but the transcript from Mutation A will not.\n\nE. NMD is not relevant as the EJC is only deposited on introns, not exons.", "solution": "The problem asks us to determine whether mRNA transcripts from two different mutant alleles of the `NEURONIN` (`NRN1`) gene will be targeted by the Nonsense-Mediated Decay (NMD) pathway. The rule for NMD activation is provided: the premature termination codon (PTC) must be located more than a critical distance `D_crit = 55` nucleotides upstream of the final exon-junction complex (EJC).\n\nFirst, let's establish the structure of the fully spliced `NRN1` mRNA by calculating the cumulative nucleotide positions at the end of each exon. These positions correspond to the locations of the EJCs. The lengths are given as: Exon 1 = 90 nt, Exon 2 = 120 nt, Exon 3 = 150 nt, Exon 4 = 110 nt, Exon 5 = 180 nt.\n\nThe position of the end of each exon (and thus the location of the subsequent EJC) relative to the start of the coding sequence (CDS) is:\n*   End of Exon 1 (location of EJC 1-2): 90 nt\n*   End of Exon 2 (location of EJC 2-3): 90 + 120 = 210 nt\n*   End of Exon 3 (location of EJC 3-4): 210 + 150 = 360 nt\n*   End of Exon 4 (location of EJC 4-5): 360 + 110 = 470 nt\n\nThe final exon-junction complex is the one preceding the last exon. Since `NRN1` has 5 exons, the final EJC is the one between Exon 4 and Exon 5. Its position is at the 470 nt mark from the start of the CDS.\n\nNow, we analyze each mutation separately.\n\n**Analysis of Mutation A:**\nThe PTC is located 80 nucleotides into the sequence of Exon 2. To find its absolute position in the spliced mRNA, we add the length of the preceding exon(s).\n*   Position of PTC from Mutation A = (Length of Exon 1) + 80 nt\n*   Position of PTC (A) = 90 nt + 80 nt = 170 nt\n\nNext, we calculate the distance between this PTC and the final EJC.\n*   Distance = (Position of final EJC) - (Position of PTC (A))\n*   Distance = 470 nt - 170 nt = 300 nt\n\nWe compare this distance to the critical distance `D_crit = 55` nt.\n*   Is 300 nt > 55 nt? Yes.\n*   Since the distance is greater than `D_crit`, the mRNA transcript resulting from Mutation A will be targeted for degradation by the NMD pathway.\n\n**Analysis of Mutation B:**\nThe PTC is located 100 nucleotides into the sequence of Exon 4. We find its absolute position by summing the lengths of all preceding exons.\n*   Position of PTC from Mutation B = (Length of Exon 1 + Exon 2 + Exon 3) + 100 nt\n*   Position of PTC (B) = (90 + 120 + 150) nt + 100 nt = 360 nt + 100 nt = 460 nt\n\nNext, we calculate the distance between this PTC and the final EJC.\n*   Distance = (Position of final EJC) - (Position of PTC (B))\n*   Distance = 470 nt - 460 nt = 10 nt\n\nWe compare this distance to the critical distance `D_crit = 55` nt.\n*   Is 10 nt > 55 nt? No.\n*   Since the distance is not greater than `D_crit`, the NMD pathway will not be triggered. The mRNA transcript from Mutation B will escape NMD, likely leading to the translation of a truncated, and probably non-functional, protein.\n\n**Conclusion:**\nThe transcript from Mutation A is degraded by NMD, while the transcript from Mutation B is not. This corresponds to option C. Option E is incorrect because the EJC is deposited on the mRNA at the exon-exon junction after intron removal, making its position relevant to the coding sequence in the mature mRNA.", "answer": "$$\\boxed{C}$$", "id": "2336778"}]}